Skip to content

Beisol Pharma Lubbeek

Active
Private limited companyfounded 2021active for 5 yearsStaatsbaan(LUB) 187, 3210 Lubbeek, Belgium11 active companies are registered at this addressKBO/BCE: BE 0773.648.838
Summary

The computed 12-month bankruptcy probability of Beisol Pharma Lubbeek is 2.3% (moderate). The 2026 annual accounts show equity of €12,275 and a net result of €3,300. Equity is growing by about 37% per year across the filed financial years. Its solvency ranks better than 32% of 432 sector peers (NACE 47, financial year 2026). The company has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals.

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€30,000turnover 2026
Equity
€12,275
Profit
€3,300
Financial health
52 Fair Checked score 2026
Bankruptcy probabilitywithin 12 months
2.3%
Structure
Accounts 26 days early0 of 1 deed read
Why 52raises riskFounded in 2021Liquidity: current ratio 0.05, cash €43Sector: Retail trade (NACE 47)lowers riskSize: turnover €30,000, total assets €96,452Show the evidence

Checked score

Score 2026
52 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 43% of its sector peers (NACE 47, micro)
Financial strength · tick = 2025
Weak
Solvency 38+5
equity 12.7% of total assets
Liquidity 2+2
short-term debt 87.3% · cash 0.0%
Profitability 82+2
return on assets 3.4%
Bankruptcy probability, 12 months
2.3% Moderate
0%0.5%1.5%4%10%≥ 25%

About 2 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,211 companies, NACE 47, micro)
Last 24 months 11-2024: 3.5% 12-2024: 3.5%● unchanged vs 11-2024 01-2025: 3.5%● unchanged vs 12-2024 02-2025: 3.5%● unchanged vs 01-2025 03-2025: 3.5%● unchanged vs 02-2025 04-2025: 3.6%▲ +0.1 percentage points vs 03-2025highest value 05-2025: 3.2%▼ -0.4 percentage points vs 04-2025 06-2025: 3.1%▼ -0.1 percentage points vs 05-2025 07-2025: 3.2%▲ +0.1 percentage points vs 06-2025 08-2025: 3.3%▲ +0.1 percentage points vs 07-2025 09-2025: 3.2%▼ -0.1 percentage points vs 08-2025 10-2025: 3.2%● unchanged vs 09-2025 11-2025: 2.8%▼ -0.4 percentage points vs 10-2025 12-2025: 2.8%● unchanged vs 11-2025 01-2026: 2.8%● unchanged vs 12-2025 02-2026: 2.8%● unchanged vs 01-2026 03-2026: 2.8%● unchanged vs 02-2026 04-2026: 2.9%▲ +0.1 percentage points vs 03-2026 05-2026: 2.9%● unchanged vs 04-2026 06-2026: 2.8%▼ -0.1 percentage points vs 05-2026 07-2026: 3.0%▲ +0.2 percentage points vs 06-2026 08-2026: 3.0%● unchanged vs 07-2026 09-2026: 2.8%▼ -0.2 percentage points vs 08-2026 10-2026: 2.3%▼ -0.5 percentage points vs 09-2026lowest value
Credit of up to €500 on 30-day terms is acceptable
Liquidity insufficient (current ratio 0.05, compared with 0.0 in 2025, below 1; short-term debt: 87.3% and cash: 0% of total assets), and 87.3% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 29% on solvency, 4% on liquidity, 75% on profitability and 64% on growth.

The bankruptcy probability was computed on 16-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
raises risk · Founded in 2021
Companies of this age fail more often than older ones; how much that weighs depends on the rest of its profile.
KBO
raises risk · Liquidity: current ratio 0.05, cash €43
NBB · annual accounts
lowers risk · Size: turnover €30,000, total assets €96,452
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2026 was due by 31-10-2026 and was filed on 05-10-2026, 26 days ahead of the deadline.
NBB · 4 filings
Deviation from the deadline
2026
26 days early
2025
10 days early
2024
16 days early
2023
12 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 4 accounts on average 16 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-03-2027 and is due by 31-10-2027. Nothing is late today. The company usually files around 17 October (4 of the last 4 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
17-10-2026 today31-03-2027 year end31-10-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2026 · abbreviated…
  2. Annual accounts filedfinancial year 2025 · micro…
  3. Annual accounts filedfinancial year 2024 · micro…

Key points

  • Caution: Among the weakest 20% on equitysector median €194,583 · 433 companies €12,275 View
  • Positive: Always filed on timeaccounts within the deadline every year 4 years View
  • Turnover 20264 financial years filed €30,000 View

By topic

Financials

Financial year
2026
Turnover
€30,000
Profit
€3,300
Solvency
12.7%
Turnover=
Net result
20232026
Go to Financials

Timeline

Events
5
Since
2023
Next accounts
by 31-10-2027
  1. 31-03-2024Back to profit
  2. 19-10-2023Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
08-09-2021
Year ends
31-03
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.